ContraVir Pharmaceuticals Inc (OTCBB - OTCQB:CTRV)

Data as of 3:21pm ET
 +0.03 / +1.15%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

ContraVir Pharmaceuticals, Inc. is a development stage biopharmaceutical company which is focused primarily on the development of drugs to treat herpes zoster, or shingles. The company currently developing a compound called FV-100 for the treatment of shingles. ContraVir Pharmaceuticals was founded on May 15, 2013 and is Headquartered in New York, NY.

Contact Information

ContraVir Pharmaceuticals, Inc.
420 Lexington Avenue
New York New York 10170
P:(212) 297-0020
Investor Relations:
(212) 584-7610



Individual stakeholders0.16%
Mutual fund holders0.06%
Other institutional0.00%

Top Executives

James E. SapirsteinChief Executive Officer & Director
William HornungChief Financial Officer
John Z. Sullivan-BólyaiChief Medical Officer
Gem GokmenHead-Media Relations

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.